Merck & Co., Inc. is 310.2x more valuable than Corvus Pharmaceuticals, Inc. by market capitalization ($293.16 B vs $945.18 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRVS | MRK |
|---|---|---|
| Market cap | $945.18 M | $293.16 B |
| US-listed rank | #2651 | #44 |
| Revenue (latest FY) | - | $65.01B |
| Net income (latest FY) | -$15.30M | $18.25B |
| Net margin | - | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 570 | 996 |
Merck & Co., Inc. is 310.2x more valuable than Corvus Pharmaceuticals, Inc. by market capitalization ($293.16 B vs $945.18 M).
Full pages: Corvus Pharmaceuticals, Inc. and Merck & Co., Inc., or browse the full rankings.